These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Talc poudrage in the treatment of pleural effusion due to cancer. CAMISHION RC; GIBBON JH; NEALON TF Surg Clin North Am; 1962 Dec; 42():1521-6. PubMed ID: 14018059 [No Abstract] [Full Text] [Related]
48. [Pleuroperitoneal shunt in the treatment of exudative carcinomatous pleurisy]. de Boer WA; Klaassen CH; Kunst MW Ned Tijdschr Geneeskd; 1988 Aug; 132(33):1549. PubMed ID: 3173527 [No Abstract] [Full Text] [Related]
49. Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage. Aelony Y J Clin Oncol; 2006 Oct; 24(28):4667; author reply 4667-8. PubMed ID: 17008709 [No Abstract] [Full Text] [Related]
50. Thoracoscopic management of malignant pleural effusion. Bal S; Hasan SS Int Surg; 1993; 78(4):324-7. PubMed ID: 8175261 [TBL] [Abstract][Full Text] [Related]